Rockpoint-Lung-COVID-Enduring - 35621P2VRCev - 2020-09-25-01

Access Activity

Overview / Abstract:

Target Audience

This activity is intended for clinicians responsible for the daily management of patients with lung cancers.

Program Overview

Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine requires special attention, particularly because symptoms of COVID-19 infection are similar to common adverse events associated with lung cancer treatment.

This activity, “Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide clinicians with the most up-to-date guidance on managing lung cancer during the current pandemic, including information on the pathophysiology of Sars-Cov-2, the risk of infection in patients with lung cancer, and strategies to manage patient care and counsel through telemedicine.


Welcome and Introduction
Understanding the Pathophysiology of COVID-19
Recognizing the Risk of COVID-19 in Patients with Lung Cancer
Managing Patients with Lung Cancer During the COVID-19 Pandemic
Q&A Session and Concluding Remarks
Learning Objectives

This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.

This program is designed to address ACPE competencies, including foundational knowledge and essentials for practice and care.

At the conclusion of this education, participants should be able to:

Discuss the most current understanding of the pathophysiology of COVID-19
Recognize and evaluate factors that increase risk of COVID-19 among patients with lung cancer
Integrate consensus recommendations for the safe and effective management of patients with lung cancer during the COVID-19 pandemic
Provide counsel to patients with lung cancer regarding concerns or fears related to COVID-19


Oct 15, 2021


Nursing CNE, Pharmacy CPE, Physician CME



Credits / Hours

1.0 AMA PRA Category 1 Credit(s)™



Presenters / Authors / Faculty

Steering Committee

Sandra Cuellar, PharmD, BCOP
Associate Professor
University of Illinois at Chicago College of Pharmacy
Clinical Oncology Pharmacist, UI Health
Chicago, IL

J. Morgan Freiman, MD, MSc
Infectious Diseases Physician
Director of Antimicrobial Stewardship
Lahey Hospital and Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, MA

Antonio Passaro, MD, PhD
Division of Thoracic Oncology
European Institute of OncologyBIO
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
Milan, Italy

Beth Sandy, MSN, CRNP
Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA

Sponsors / Supporters / Grant Providers

Daiichi Sankyo.

Keywords / Search Terms

Relias LLC FREE CME., Relias LLC., Lung, COVID Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.